IHS Chemical Week

People & Business :: Corporate Social Responsibility

Australia Warns of Tainted Batches of Heparin

8:46 AM MDT | April 7, 2008 | Alex Scott

Authorities in Australia have warned that four batches of AstraZeneca’s (AZ) blood-thinning drug heparin are contaminated. AZ is the latest in a series of companies, including Baxter Healthcare (Deerfield, IL), that has identified contamination in its heparin products, and all of the companies source their heparin active pharma ingredients (APIs) from China. Regulatory bodies in Denmark, France, Italy, Japan, Switzerland, and the U.S. say they have removed heparin from their markets to protect patients. Australia’s regulatory agency for...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa